Lab Rede

What Lab Rede does

Lab Rede S/A is a Brazilian reference laboratory network founded in 2000 and headquartered in Belo Horizonte, Minas Gerais, that operates exclusively as a B2B support laboratory for other clinical laboratories rather than serving patients directly. The company is constituted as a closed-capital Sociedade Anônima formed exclusively by companies in the diagnostic sector, with over 200 partner laboratories across Brazil sending biological samples for specialized testing that those laboratories cannot economically perform in-house. Lab Rede's core diagnostic portfolio spans genetic and genomic testing (from targeted investigations such as Factor V Leiden and fetal sexing through CGH-array 750K, exome sequencing, and full genome analysis using Next Generation Sequencing), component-resolved IgE allergy diagnostics, molecular PCR panels (including a Monkeypox PCR test launched in August 2022), and specialized assays such as Freelite for multiple myeloma delivered via a partnership with Binding Site.

The technical platform centers on a high-automation production line optimized for low-volume, high-cost tests with full sample and data traceability and interface capability to partner laboratory information systems (LIS). Supporting services include a Test Manual, the "Projeto Guardiões" customer-relationship program, integrated logistics with monitored sample transport, advanced pre-analytical screening, multidisciplinary scientific advisory, the Rede Digital EAD training platform, and a customer portal. Direct system integration with partner LIS environments is positioned as a switching-cost lever and operational differentiator.

Commercially, Lab Rede operates a sales-led go-to-market with commercial consultants managing acquisition and retention of member laboratories, augmented by scientific content marketing through the Lab.com and LabInforma publications, active participation in major Brazilian clinical-laboratory congresses (CBAC, CBPC, CBAEM, FILIS), and recurring in-person and remote training programs. The company holds triple accreditation (PALC, DICQ, and ONA Nível III — the highest ONA level), maintains operating and sanitary licenses valid through 2026–2028, and is governed by a Board of Directors elected for the 2022–2025 term with Isadora Bittar Floriani as President. Revenue is generated on a professional-services basis via per-test processing fees negotiated with member laboratories; pricing is not publicly disclosed. No external funding rounds, M&A activity, or subsidiaries are disclosed, and the company remains privately held.

Name

Lab Rede

Legal name

Lab Rede S/A

Website

https://labrede.com.br

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Lab Rede is a Brazilian reference laboratory network, founded in 2000 in Belo Horizonte, that processes specialized diagnostic tests for over 200 partner laboratories across Brazil, spanning genetic, molecular, allergy, and high-complexity clinical assays on a B2B basis.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industry

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL)

Keywords

• Clinical laboratory services
• Reference diagnostic network
• Genetic testing services
• Molecular diagnostics testing
• Allergy IgE diagnostics

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Diagnostic Services: Lab Rede processes diagnostic tests for member laboratories in their network. They receive patient samples from partner laboratories, perform specialized tests, and return results. Lab Rede maintains contractual service relationships with network members throughout the national territory, processing examinations with patient materials sent by these laboratories without serving patients directly.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Lab Rede operates a B2B reference laboratory network providing high-complexity diagnostic testing services exclusively to partner clinical laboratories across Brazil. Member laboratories send biological samples to Lab Rede's automated facility in Belo Horizonte, where specialized tests — including genetic/genomic analysis, component-resolved IgE allergy diagnostics, molecular PCR panels, and assays such as Freelite — are processed and results returned through integrated laboratory information systems. Revenue is generated through service-fee contracts with the 200+ member laboratories rather than direct patient billing.

Product overview

Lab Rede is a reference laboratory network (Laboratório de Referência em Diagnósticos Especializados) providing clinical analysis support services to over 200 partner laboratories across Brazil. The company operates as a platform connecting member laboratories with specialized testing capabilities, processing diagnostic materials without serving patients directly. The core portfolio includes genetic testing services (from point investigations to complex analyses like exome and genome), IgE allergy testing using component-resolved diagnostics, molecular PCR testing (including Monkeypox, HPV, respiratory panels), and specialized tests such as Freelite for multiple myeloma monitoring. Supporting sub-products include a Test Manual, Customer Relationship Management (CAC), Technical-Operational Excellence services with automated production, Logistics for sample transport, Informatization for system integration, Multidisciplinary Scientific Advisory, and Advanced Screening. The network also provides a Customer Portal for client access.

Differentiator

Problem solved

Functional benefit

Products and services

• Lab Rede Reference Laboratory Support Network Core B2B service in which Lab Rede receives biological samples from 200+ partner clinical laboratories across Brazil and processes specialized/high-complexity diagnostic tests, returning results via integrated information systems. The network does not serve patients directly.
• Genetic Testing Services Comprehensive genetic testing services for partner laboratories, ranging from point investigations (Factor V Leiden, prothrombin gene mutation, HLA-B27, lactose intolerance, fetal sexing) to complex analyses including G-banding karyotype, CGH-array 750K, exome sequencing via NGS, and genome testing.
• IgE Allergy Testing Specific IgE testing for allergen components (Component-resolved Diagnosis) for partner laboratories, providing clinicians with detailed allergy diagnostic information for treatment decisions.
• Hereditary Breast and Ovarian Cancer Panel Genetic panel test indicated for patients with family history of breast and ovarian cancer to identify genetic predisposition.
• Freelite Test for Multiple Myeloma Quantification of serum free light chains kappa and lambda in serum, used for diagnosis and monitoring of Multiple Myeloma per International Myeloma Working Group guidelines.
• Monkeypox PCR Test Molecular PCR test for Monkeypox virus detection, available to physician-prescribed patients through the partner laboratory network.
• Fetal Sexing Test (Sexagem Fetal) Fetal sexing genetic test available to partner laboratories with improved turnaround time, sample stability and logistics.
• Sample Logistics Service Dedicated sample transportation service with integrity guarantee, agile and secure transport, constant monitoring, and compliance with current legislation for partner laboratories.
• LIS Informatization / System Integration Service Direct connection with client laboratory information systems enabling reports, queries, and direct export of results to the client system, with personalized support for integration processes.
• Multidisciplinary Scientific Advisory Multidisciplinary team providing differentiated consulting for result discussion and technical questions, plus periodic newsletters covering laboratory medicine, quality, and legislation.
• Customer Portal (Área do Cliente) Online customer area for registered partner laboratories to access services, view results, and manage their testing needs.

Quantifiable outcome

• Over 100 new tests added to service menu in 2021
• +2 more outcomes

Named customers6 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• ShiftcoreTechnology or Integration · 1 January 2022Shift is a Brazilian software company specializing in diagnostic medicine technology solutions. The partnership has been ongoing for 17 years, providing Lab Rede with strategic technology support for decision-making, intelligence, efficiency, agility, and improved patient experience through technology. Marcelo Lorencin is the CEO and founder of Shift.
• Binding SitecoreTechnology or IntegrationPartnership with Binding Site for the Freelite test, which quantifies free light chains kappa and lambda in serum. Through this partnership, Lab Rede became the first laboratory in Minas Gerais to perform the Freelite test for diagnosis and monitoring of Multiple Myeloma.
• OFAC BrasilminorOthersOFAC Brasil (Organização Feminina de Análises Clínicas) is an organization that shares information, exchanges ideas, and discusses matters related to clinical analyses to collaborate with small and medium laboratories. Lab Rede was awarded 'Rede Destaque de Laboratórios' at their 4th Scarpin Microscópio event.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: International testing services group operating clinical diagnostics laboratories alongside other testing capabilities; comparable specialty clinical reference testing franchise in selected markets.
• Grupo Sabin: Brazilian diagnostics group with national coverage and a broad specialty-testing menu, comparable in offering (though larger and more vertically integrated) to Lab Rede.
• Laboratory Corporation of America (Labcorp): Global clinical laboratory network offering routine and specialty reference testing (including genetics and immunoassay) to physicians, hospitals, and partner labs — comparable menu breadth though substantially larger and more diversified.
• DASA (Diagnósticos da América): Brazil's largest integrated diagnostics company offering a full suite of clinical laboratory and imaging services. While much larger and vertically integrated, DASA competes with Lab Rede's partner labs and can internalize reference testing.
• Fleury: Major Brazilian diagnostics chain with extensive specialty testing capacity after absorbing Hermes Pardini. Competes with Lab Rede for partner-lab referral volumes and can bypass the reference-lab layer entirely.
• Quest Diagnostics: Large US-based clinical laboratory network with a substantial reference/ esoteric testing franchise — broadly comparable in capabilities (genetics, immunoassay, molecular) though operating at much greater scale and with different reimbursement context.

Direct peers

• Synlab: Pan-European clinical laboratory and reference-testing operator with a comparable B2B reference laboratory model and significant specialty diagnostics exposure.
• Hermes Pardini: Brazilian reference laboratory network historically known for esoteric and high-complexity testing for other clinical labs and hospitals — directly comparable in business model to Lab Rede's B2B reference positioning.
• Unilabs: European-headquartered clinical reference laboratory network with operations across multiple countries, operating an analogous B2B reference model serving partner laboratories and hospitals.

Regional players

• Sonic Healthcare: Australian-headquartered clinical pathology and reference laboratory operator with operations in multiple geographies — comparable reference-lab business model serving partner clinicians and labs, though primarily outside Latin America.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/labrede

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lab Rede